To further confirm that IFN induces the lncRNA GAS5 via the JAK‐STAT signaling pathway, we simultaneously treated esophageal cancer cells with IFN‐β and the JAK inhibitor ruxolitinib. This evidence concerns the gene IFNB1 and esophageal cancer.